The 30-day risks of hospitalization were 17.5%, 15.9%, and 14.4% for COVID, influenza, and RSV, respectively, during the 2022 ...

Pregnant women across the Northern Territory now have free access to protection against the leading cause of hospitalisation ...

UK contract research organization hVIVO (AIM: HVO) is gearing up to test an inhaled antiviral candidate, IN-002, for ...

U.S. surges of COVID-19, influenza, respiratory syncytial virus (RSV) and norovirus have collectively been dubbed a "quad-demic." Here what you can do.

Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...

From today, February 3, pregnant women in Australia will be eligible for a free RSV vaccine under the National Immunisation ...

His mother, Amberlie Reinertsen, says Mason has had lung complications since birth but has never been this sick before.

The CDC monitors RSV through the Respiratory Syncytial Virus Hospitalization Surveillance Network (RSV-NET), which comprises 161 counties and county-equivalents in 13 states. The network ...

Flu and RSV are packing a post-holiday one-two punch, sending people into Erie's emergency departments and medical offices ...

In the wake of multiple cases of human metapneumovirus (hMPV) in India, multiple questions about its causes and symptoms seem ...

It’s what’s being called a “Quad-demic,” with cases on the rise for COVID-19, Respiratory syncytial virus (RSV), Influenza, ...

As of Jan. 20, the CDC reports that RSV activity has peaked in most of the U.S., particularly among young children—a group ...